Compare NXDT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NXDT | ANIK |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.6M | 192.4M |
| IPO Year | N/A | 1996 |
| Metric | NXDT | ANIK |
|---|---|---|
| Price | $4.51 | $14.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 137.1K | 134.2K |
| Earning Date | 01-01-0001 | 06-02-2026 |
| Dividend Yield | ★ 9.66% | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | ★ 0.99 | N/A |
| Revenue | N/A | ★ $112,819,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | N/A | $7.42 |
| P/E Ratio | $4.51 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.55 | $7.90 |
| 52 Week High | $5.26 | $16.45 |
| Indicator | NXDT | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 47.14 | 72.42 |
| Support Level | $4.35 | $9.43 |
| Resistance Level | $5.04 | $15.01 |
| Average True Range (ATR) | 0.26 | 0.74 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 20.69 | 84.06 |
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.